112 related articles for article (PubMed ID: 31307200)
1. The value of human epididymis protein 4 (HE4) as a serum tumor marker for accurate bone metastases finding by whole-body bone scintigraphy in lung cancer patients.
Weissensteiner J; Babusikova E
Neoplasma; 2019 Nov; 66(6):1024-1030. PubMed ID: 31307200
[TBL] [Abstract][Full Text] [Related]
2. [The possibility of the serum concentration of osteocalcin determination in lung cancer patients with suspected bone metastases].
Weissensteiner J; Babušíková E
Klin Onkol; 2015; 28(1):51-6. PubMed ID: 25692755
[TBL] [Abstract][Full Text] [Related]
3. Bone Metabolism of the Patient with a Malignant Melanoma during the Entry Examination and the Check-up of Whole-body Bone Scintigraphy.
Weissensteiner J; Babušíková E
Prague Med Rep; 2016; 117(2-3):129-134. PubMed ID: 27668530
[TBL] [Abstract][Full Text] [Related]
4. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
Mo D; He F
Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
[TBL] [Abstract][Full Text] [Related]
5. Clinical Usefulness of Human Epididymis Protein 4 in Lung Cancer.
Choi SI; Jang MA; Jeon BR; Shin HB; Lee YK; Lee YW
Ann Lab Med; 2017 Nov; 37(6):526-530. PubMed ID: 28840992
[TBL] [Abstract][Full Text] [Related]
6. Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer.
Nagy B; Bhattoa HP; Steiber Z; Csobán M; Szilasi M; Méhes G; Müller M; Lázár J; Kappelmayer J; Antal-Szalmás P
Clin Chem Lab Med; 2014 Nov; 52(11):1639-48. PubMed ID: 24829194
[TBL] [Abstract][Full Text] [Related]
7. Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer.
Zeng Q; Liu M; Zhou N; Liu L; Song X
Clin Chim Acta; 2016 Apr; 455():102-6. PubMed ID: 26851650
[TBL] [Abstract][Full Text] [Related]
8. Correlation between bone scintigraphy and tumor markers in patients with breast carcinoma.
Begić A; Kucukalić-Selimović E; Obralić N; Durić O; Lacević N; Skopljak A
Bosn J Basic Med Sci; 2006 Feb; 6(1):75-7. PubMed ID: 16533185
[TBL] [Abstract][Full Text] [Related]
9. [The usefulness of early whole body bone scintigraphy in the detection of bone metastasis from prostatic cancer].
Otsuka N; Fukunaga M; Furukawa Y; Tanaka H
Kaku Igaku; 1994 Jun; 31(6):541-50. PubMed ID: 7520953
[TBL] [Abstract][Full Text] [Related]
10. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases.
Escudero JM; Auge JM; Filella X; Torne A; Pahisa J; Molina R
Clin Chem; 2011 Nov; 57(11):1534-44. PubMed ID: 21933899
[TBL] [Abstract][Full Text] [Related]
11. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer.
Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK
Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590
[TBL] [Abstract][Full Text] [Related]
12. Comparison of whole-body MRI and bone scintigraphy in the detection of bone metastases in renal cancer.
Sohaib SA; Cook G; Allen SD; Hughes M; Eisen T; Gore M
Br J Radiol; 2009 Aug; 82(980):632-9. PubMed ID: 19221182
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.
Li X; Chen K; Li J; Tang X; Ruan H; Guan M
Front Immunol; 2024; 15():1339914. PubMed ID: 38304432
[TBL] [Abstract][Full Text] [Related]
14. Comparison of bone scintigraphy with bone markers in the diagnosis of bone metastasis in lung carcinoma patients.
Ebert W; Muley T; Herb KP; Schmidt-Gayk H
Anticancer Res; 2004; 24(5B):3193-201. PubMed ID: 15510610
[TBL] [Abstract][Full Text] [Related]
15. [Detection of bone metastasis of prostate cancer - comparison of whole-body MRI and bone scintigraphy].
Ketelsen D; Röthke M; Aschoff P; Merseburger AS; Lichy MP; Reimold M; Claussen CD; Schlemmer HP
Rofo; 2008 Aug; 180(8):746-52. PubMed ID: 18512192
[TBL] [Abstract][Full Text] [Related]
16. The semiquantitative bone scintigraphy index correlates with serum tartrate-resistant acid phosphatase activity in breast cancer patients with bone metastasis.
Tsai SH; Chen CY; Ku CH; Janckila AJ; Yam LT; Yu JC; Chuang KW; Chao TY
Mayo Clin Proc; 2007 Aug; 82(8):917-26. PubMed ID: 17673059
[TBL] [Abstract][Full Text] [Related]
17. HE4 tissue expression and serum HE4 levels in healthy individuals and patients with benign or malignant tumors: a systematic review.
Karlsen NS; Karlsen MA; Høgdall CK; Høgdall EV
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2285-95. PubMed ID: 25169975
[TBL] [Abstract][Full Text] [Related]
18. Human epididymis protein 4 immunostaining of malignant ascites differentiates cancer of Müllerian origin from gastrointestinal cancer.
Stiekema A; Van de Vijver KK; Boot H; Broeks A; Korse CM; van Driel WJ; Kenter GG; Lok CA
Cancer Cytopathol; 2017 Mar; 125(3):197-204. PubMed ID: 28199067
[TBL] [Abstract][Full Text] [Related]
19. Human epididymis protein 4 (HE4) in benign and malignant diseases.
Hertlein L; Stieber P; Kirschenhofer A; Krocker K; Nagel D; Lenhard M; Burges A
Clin Chem Lab Med; 2012 Dec; 50(12):2181-8. PubMed ID: 23093276
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of whole-body MRI and bone scintigraphy for the detection of bone metastases.
Balliu E; Boada M; Peláez I; Vilanova JC; Barceló-Vidal C; Rubio A; Galofré P; Castro A; Pedraza S
Clin Radiol; 2010 Dec; 65(12):989-96. PubMed ID: 21070903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
